Literature DB >> 25421805

Risk factors and management for early and late intrahepatic recurrence of solitary hepatocellular carcinoma after curative resection.

Zhangjun Cheng1, Pinghua Yang, Shuping Qu, Jiahua Zhou, Jue Yang, Xinwei Yang, Yong Xia, Jun Li, Kui Wang, Zhenlin Yan, Dong Wu, Baohua Zhang, Norbert Hüser, Feng Shen.   

Abstract

BACKGROUND: Intrahepatic recurrence is a significant problem for patients who have undergone a hepatic resection for hepatocellular carcinoma (HCC). The objective of the present study was to identify risk factors and evaluate the management of early and late recurrence of solitary HCC after curative resection.
METHODS: Included in this study were 816 patients with solitary HCC who underwent a curative partial hepatectomy. Intrahepatic recurrence in these patients was followed up retrospectively. Prognosis and therapy for the recurrence were investigated and analysed.
RESULTS: Early and late intrahepatic recurrence occurred in 423 patients and 199 patients, respectively. Multivariate analysis showed that a tumour diameter >5 cm, the absence of a tumour capsule and the presence of microvascular invasion were correlated with early recurrence, whereas cirrhosis and alpha-fetal protein >400 μg/l were independent risk factors contributing to late recurrence. The 5-year survival of HCC patients with early recurrence was significantly lower than that of patients with late recurrence. Further curative treatment for intrahepatic recurrence offered a 5-year overall survival of 56.0%, which was better than alternative management.
CONCLUSION: Early and late recurrences of solitary HCC after curative resection are associated with different predictive factors. The time to recurrence and further curative treatment after recurrence were the best predictors of survival post recurrence.
© 2014 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2014        PMID: 25421805      PMCID: PMC4402053          DOI: 10.1111/hpb.12367

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  29 in total

Review 1.  Management of HCC.

Authors:  Carlos Rodríguez de Lope; Silvia Tremosini; Alejandro Forner; María Reig; Jordi Bruix
Journal:  J Hepatol       Date:  2012       Impact factor: 25.083

2.  Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications.

Authors:  Nazario Portolani; Arianna Coniglio; Sara Ghidoni; Mara Giovanelli; Anna Benetti; Guido Alberto Massimo Tiberio; Stefano Maria Giulini
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

3.  Actual 10-year survival following hepatectomy for hepatocellular carcinoma.

Authors:  Bernardo Franssen; Ghalib Jibara; Parissa Tabrizian; Myron E Schwartz; Sasan Roayaie
Journal:  HPB (Oxford)       Date:  2013-12-24       Impact factor: 3.647

4.  Overexpression of aspartyl-(asparaginyl)-beta-hydroxylase in hepatocellular carcinoma is associated with worse surgical outcome.

Authors:  Kui Wang; Jian Liu; Zhen-Lin Yan; Jun Li; Le-Hua Shi; Wen-Ming Cong; Yong Xia; Qi-Fei Zou; Tao Xi; Feng Shen; Hong-Yang Wang; Meng-Chao Wu
Journal:  Hepatology       Date:  2010-07       Impact factor: 17.425

5.  Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.

Authors:  Adrian M Di Bisceglie; Richard K Sterling; Raymond T Chung; James E Everhart; Jules L Dienstag; Herbert L Bonkovsky; Elizabeth C Wright; Gregory T Everson; Karen L Lindsay; Anna S F Lok; William M Lee; Timothy R Morgan; Marc G Ghany; David R Gretch
Journal:  J Hepatol       Date:  2005-09       Impact factor: 25.083

6.  Predicting recurrence patterns after resection of hepatocellular cancer.

Authors:  Ser Yee Lee; Ioannis T Konstantinidis; Anne A Eaton; Mithat Gönen; T Peter Kingham; Michael I D'Angelica; Peter J Allen; Yuman Fong; Ronald P DeMatteo; William R Jarnagin
Journal:  HPB (Oxford)       Date:  2014-07-16       Impact factor: 3.647

7.  Analysis of the risk factors of untransplantable recurrence after primary curative resection for patients with hepatocellular carcinoma.

Authors:  Cheng-Maw Ho; Chao-Ying Wu; Po-Huang Lee; Hong-Shiee Lai; Ming-Chih Ho; Yao-Ming Wu; Rey-Heng Hu
Journal:  Ann Surg Oncol       Date:  2013-03-16       Impact factor: 5.344

8.  Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma.

Authors:  Ke-Qin Hu; Namgyal L Kyulo; Nelson Lim; Brijie Elhazin; Donald J Hillebrand; Tracy Bock
Journal:  Am J Gastroenterol       Date:  2004-05       Impact factor: 10.864

Review 9.  Surgical management of hepatocellular carcinoma: is the jury still out?

Authors:  G Morris-Stiff; D Gomez; N de Liguori Carino; K R Prasad
Journal:  Surg Oncol       Date:  2008-12-05       Impact factor: 3.279

10.  Clinicopathologic features between multicentric occurence and intrahepatic metastasis of multiple hepatocellular carcinomas related to HBV.

Authors:  Jian Wang; Qiang Li; Yan Sun; Hong Zheng; Yunlong Cui; Haixin Li; Hongyuan Zhou; Xishan Hao
Journal:  Surg Oncol       Date:  2008-07-18       Impact factor: 3.279

View more
  48 in total

1.  The Impact of Tumor Differentiation on the Prognosis of HBV-Associated Solitary Hepatocellular Carcinoma Following Hepatectomy: A Propensity Score Matching Analysis.

Authors:  Junyi Shen; Jiaye Liu; Chuan Li; Tianfu Wen; Lvnan Yan; Jiayin Yang
Journal:  Dig Dis Sci       Date:  2018-05-07       Impact factor: 3.199

2.  Impact of surgical complications on the risk of hepatocellular carcinoma recurrence after hepatic resection.

Authors:  Riccardo Pravisani; Umberto Baccarani; Miriam Isola; Gianluigi Adani; Dario Lorenzin; Giovanni Terrosu; Andrea Risaliti
Journal:  Updates Surg       Date:  2017-09-15

3.  Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China.

Authors:  Xin-Fei Xu; Hao Xing; Jun Han; Zhen-Li Li; Wan-Yee Lau; Ya-Hao Zhou; Wei-Min Gu; Hong Wang; Ting-Hao Chen; Yong-Yi Zeng; Chao Li; Meng-Chao Wu; Feng Shen; Tian Yang
Journal:  JAMA Surg       Date:  2019-03-01       Impact factor: 14.766

4.  CISD2 associated with proliferation indicates negative prognosis in patients with hepatocellular carcinoma.

Authors:  Bin Chen; Shunli Shen; Jian Wu; Yunpeng Hua; Ming Kuang; Shaoqiang Li; Baogang Peng
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

5.  Outcomes of Salvage Liver Transplantation and Re-resection/Radiofrequency Ablation for Intrahepatic Recurrent Hepatocellular Carcinoma: A New Surgical Strategy Based on Recurrence Pattern.

Authors:  Xiaoyun Zhang; Chuan Li; Tianfu Wen; Wei Peng; Lunan Yan; Jiayin Yang
Journal:  Dig Dis Sci       Date:  2017-12-14       Impact factor: 3.199

6.  Recurrence of Hepatocellular Carcinoma After Laparoscopic Hepatectomy: Risk Factors and Treatment Strategies.

Authors:  Xiaodong Xu; Jiahui Chen; Feiran Wang; Qinggan Ni; Ullah Naimat; Zhong Chen
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2017-03-22       Impact factor: 1.878

7.  Association of Preoperative Antiviral Treatment With Incidences of Microvascular Invasion and Early Tumor Recurrence in Hepatitis B Virus-Related Hepatocellular Carcinoma.

Authors:  Zheng Li; Zhengqing Lei; Yong Xia; Jun Li; Kui Wang; Han Zhang; Xuying Wan; Tian Yang; Weiping Zhou; Mengchao Wu; Timothy M Pawlik; Wan Yee Lau; Feng Shen
Journal:  JAMA Surg       Date:  2018-10-17       Impact factor: 14.766

8.  Pathological predictive factors for late recurrence of hepatocellular carcinoma in chronic liver disease.

Authors:  Ji Hae Nahm; Hye Sun Lee; Haeryoung Kim; Sun Young Yim; Ji-Hyun Shin; Jeong Eun Yoo; Sang Hoon Ahn; Jin Sub Choi; Ju-Seog Lee; Young Nyun Park
Journal:  Liver Int       Date:  2021-03-25       Impact factor: 5.828

9.  Postoperative adjuvant transarterial chemoembolization for intrahepatic cholangiocarcinoma patients with microvascular invasion: a propensity score analysis.

Authors:  Zhangjun Cheng; Zhengqing Lei; Xiaoling Jin; Qi Zhang; Anfeng Si; Pinghua Yang; Jiahua Zhou; Daniel Hartmann; Norbert Hüser; Feng Shen
Journal:  J Gastrointest Oncol       Date:  2021-04

10.  Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma.

Authors:  Han Ah Lee; Young-Sun Lee; Beom Kyung Kim; Young Kul Jung; Seung Up Kim; Jun Yong Park; Ji Hoon Kim; Hyunggin An; Do Young Kim; Hyung Joon Yim; Sang Hoon Ahn; Jong Eun Yeon; Kwan Soo Byun; Kwang-Hyub Han; Soon Ho Um; Yeon Seok Seo
Journal:  Gut Liver       Date:  2021-05-15       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.